83 related articles for article (PubMed ID: 1382838)
21. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
22. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
Pekonen F; Partanen S; Mäkinen T; Rutanen EM
Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.
Oh Y; Müller HL; Pham H; Lamson G; Rosenfeld RG
Growth Regul; 1993 Mar; 3(1):84-7. PubMed ID: 7683543
[TBL] [Abstract][Full Text] [Related]
25. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
[TBL] [Abstract][Full Text] [Related]
27. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
[TBL] [Abstract][Full Text] [Related]
28. Identification of insulin-like growth factor binding proteins in breast cancer cells.
Yee D; Favoni RE; Lippman ME; Powell DR
Breast Cancer Res Treat; 1991 Mar; 18(1):3-10. PubMed ID: 1713084
[TBL] [Abstract][Full Text] [Related]
29. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues.
McGuire SE; Hilsenbeck SG; Figueroa JA; Jackson JG; Yee D
Cancer Lett; 1994 Feb; 77(1):25-32. PubMed ID: 7512885
[TBL] [Abstract][Full Text] [Related]
30. The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
Krzysiek J; Milewicz T; Augustowska K; Sztefko K; Ryś J; Zubel A; Pityński K; Jaszczyński P; Herman K; Basta A; Stachura J; Gregoraszczuk EŁ
Ginekol Pol; 2003 Sep; 74(9):767-74. PubMed ID: 14674122
[TBL] [Abstract][Full Text] [Related]
31. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells.
Sheikh MS; Shao ZM; Clemmons DR; LeRoith D; Roberts CT; Fontana JA
Biochem Biophys Res Commun; 1992 Mar; 183(3):1003-10. PubMed ID: 1373605
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer.
Yee D; Sharma J; Hilsenbeck SG
J Natl Cancer Inst; 1994 Dec; 86(23):1785-9. PubMed ID: 7525978
[TBL] [Abstract][Full Text] [Related]
33. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes.
Nyman T; Pekonen F
Acta Endocrinol (Copenh); 1993 Feb; 128(2):168-72. PubMed ID: 7680835
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth-factor-binding protein gene expression and protein production by human tumour cell lines.
Reeve JG; Kirby LB; Brinkman A; Hughes SA; Schwander J; Bleehen NM
Int J Cancer; 1992 Jul; 51(5):818-21. PubMed ID: 1377187
[TBL] [Abstract][Full Text] [Related]
35. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer.
Figueroa JA; Yee D
Breast Cancer Res Treat; 1992; 22(1):81-90. PubMed ID: 1384805
[TBL] [Abstract][Full Text] [Related]
36. Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and -independent human breast cancer cell lines.
Kim I; Manni A; Lynch J; Hammond JM
Mol Cell Endocrinol; 1991 Jun; 78(1-2):71-8. PubMed ID: 1718794
[TBL] [Abstract][Full Text] [Related]
37. Intracellular levels and secretion of insulin-like-growth-factor-binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells. Differential modulation by estrogens in serum-free medium.
Dubois V; Couissi D; Schonne E; Remacle C; Trouet A
Eur J Biochem; 1995 Aug; 232(1):47-53. PubMed ID: 7556169
[TBL] [Abstract][Full Text] [Related]
38. IGFBP3 mRNA expression in benign and malignant breast tumors.
Ren Z; Shin A; Cai Q; Shu XO; Gao YT; Zheng W
Breast Cancer Res; 2007; 9(1):R2. PubMed ID: 17210081
[TBL] [Abstract][Full Text] [Related]
39. Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas.
Hintz RL; Bock S; Thorsson AV; Bovens J; Powell DR; Jakse G; Petrides PE
J Urol; 1991 Oct; 146(4):1160-3. PubMed ID: 1716700
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer: further metabolic-endocrine risk markers?
Stoll BA
Br J Cancer; 1997; 76(12):1652-4. PubMed ID: 9413957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
